These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23773767)

  • 21. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
    Zeng LH; Rensing NR; Wong M
    J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mTOR dysregulation and tuberous sclerosis-related epilepsy.
    Curatolo P; Moavero R; van Scheppingen J; Aronica E
    Expert Rev Neurother; 2018 Mar; 18(3):185-201. PubMed ID: 29338461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis.
    McMahon J; Huang X; Yang J; Komatsu M; Yue Z; Qian J; Zhu X; Huang Y
    J Neurosci; 2012 Nov; 32(45):15704-14. PubMed ID: 23136410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTOR inhibition in epilepsy: rationale and clinical perspectives.
    Ostendorf AP; Wong M
    CNS Drugs; 2015 Feb; 29(2):91-9. PubMed ID: 25633849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.
    Russo E; Citraro R; Constanti A; De Sarro G
    Mol Neurobiol; 2012 Dec; 46(3):662-81. PubMed ID: 22825882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DEPDC5 as a potential therapeutic target for epilepsy.
    Myers KA; Scheffer IE
    Expert Opin Ther Targets; 2017 Jun; 21(6):591-600. PubMed ID: 28406046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy.
    Marsan E; Baulac S
    Neuropathol Appl Neurobiol; 2018 Feb; 44(1):6-17. PubMed ID: 29359340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
    Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
    Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An insight into crosstalk among multiple signaling pathways contributing to epileptogenesis.
    Gautam V; Rawat K; Sandhu A; Kumari P; Singh N; Saha L
    Eur J Pharmacol; 2021 Nov; 910():174469. PubMed ID: 34478688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alnaaim SA; Alexiou A; Papadakis M; Saad HM; Batiha GE
    Mol Med; 2023 Oct; 29(1):142. PubMed ID: 37880579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy.
    Hodges SL; Lugo JN
    Epilepsy Res; 2020 Mar; 161():106282. PubMed ID: 32036255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.
    Dello Russo C; Lisi L; Feinstein DL; Navarra P
    Glia; 2013 Mar; 61(3):301-11. PubMed ID: 23044764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
    Wong M
    Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurology of mTOR.
    Lipton JO; Sahin M
    Neuron; 2014 Oct; 84(2):275-91. PubMed ID: 25374355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy.
    Mazumder AG; Padwad YS; Singh D
    CNS Neurol Disord Drug Targets; 2016; 15(8):945-955. PubMed ID: 27306063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.
    Huang X; Zhang H; Yang J; Wu J; McMahon J; Lin Y; Cao Z; Gruenthal M; Huang Y
    Neurobiol Dis; 2010 Oct; 40(1):193-9. PubMed ID: 20566381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy.
    Zhao W; Xie C; Zhang X; Liu J; Liu J; Xia Z
    Brain Behav; 2023 Jun; 13(6):e2995. PubMed ID: 37221133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglial mTOR is Neuronal Protective and Antiepileptogenic in the Pilocarpine Model of Temporal Lobe Epilepsy.
    Zhao XF; Liao Y; Alam MM; Mathur R; Feustel P; Mazurkiewicz JE; Adamo MA; Zhu XC; Huang Y
    J Neurosci; 2020 Sep; 40(40):7593-7608. PubMed ID: 32868461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.